Oleg Nodelman's Net Worth
$0
Who is Oleg Nodelman?
Oleg Nodelman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Prothena Corp plc, Panacea Acquisition Corp. II, ANAPTYSBIO, INC, Kindred Biosciences, Inc., GENVEC INC, and AVIGEN INC \DE.
SEC CIK
Oleg Nodelman's CIK is 0001454385
Past Insider Trading and Trends
2013 was Oleg Nodelman's most active year for acquiring shares with 1 total transactions. Oleg Nodelman's most active month to acquire stocks was the month of January. 2021 saw Oleg Nodelman paying a total of $0.00 for 45,229 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $2.85
CEO and Chairman the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +72.17% | 5.31M |
$1.26 | $6,692,265.10 | 12.67M |
Sep 19 - Sep 21
| |||
Form 4
| +72.17% | 5.31M |
$1.26 | $6,692,265.10 | 12.67M |
Feb 19 - Feb 21
| |||
Form 4
| +3.07% | 488.11K |
$8.89 | $4,589,360.93 | 16.41M |
Mar 31 - Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
| +5.89% | 464.5K |
$9.89 | $4,594,593.90 | 8.35M |
Apr 9 - Apr 13
| |||
Form 4
| +162.95% | 12.86M |
$10.00 | $25,000,000.00 | 20.75M |
Feb 10
| |||
Form 4
|
∞
| 390K |
$10.00 | $3,900,000.00 | 390K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prothena Corp plc (PRTA) Snapshot price: $20.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Panacea Acquisition Corp. II No price found
CEO and Chairman the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -545.00K |
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
∞
| 545K |
$10.00 | $5,450,000.00 | 545K |
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANAPTYSBIO, INC (ANAB) Snapshot price: $35.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$21.63 |
—
| 15.04M |
May 5
| |||
Form 4
| +3.03% | 221.5K |
$23.24 | $5,147,443.53 | 7.52M |
Apr 30 - May 4
| |||
Form 4
| +2.06% | 147.3K |
$23.63 | $3,480,233.08 | 7.3M |
Apr 23 - Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kindred Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.95% | 100K |
$9.56 | $955,970.00 | 1.11M |
Sep 29
| |||
Form 4
| +4.90% | 47K |
$10.85 | $509,935.80 | 1.01M |
Aug 27 - Aug 28
| |||
Form 4
| +9.76% | 85.24K |
$10.50 | $895,092.50 | 958.43K |
Aug 25 - Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +84.53% | 400K |
$7.00 | $2,800,000.00 | 873.19K |
Dec 11 - Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||